Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 3226 AL 3240

Anti-Glutamic Acid Decarboxylase Encephalitis Presenting With Choreo-Dystonic Movements and Coexisting Electrographic Seizures

Azevedo Kauppila L, Coelho M, Franco AC, Teodoro T, Peralta AR, Bentes C, Falcão F, Albuquerque L.

Mov Disord Clin Pract. 2019 Jun 25;6(6):483-485. doi: 10.1002/mdc3.12800. eCollection 2019 Jul.

Dementia associated with disorders of the basal ganglia

Vitanova KS, Stringer KM, Benitez DP, Brenton J, Cummings DM.

J Neurosci Res. 2019 Dec;97(12):1728-1741. doi: 10.1002/jnr.24508. Epub 2019 Aug 7.

Antibody-based therapies for Huntington's disease: current status and future directions

Denis HL, David LS, Cicchetti F.

Neurobiol Dis. 2019 Dec;132:104569. doi: 10.1016/j.nbd.2019.104569. Epub 2019 Aug 6.

Validity of irritability in Huntington's disease: A scoping review

Simpson J, Dale M, Theed R, Gunn S, Zarotti N, Eccles FJR.

Cortex. 2019 Nov;120:353-374. doi: 10.1016/j.cortex.2019.06.012. Epub 2019 Jul 8.

Worsening of movement disorder following treatment with electroconvulsive therapy in a patient with Huntington's disease

Abeysundera H, Campbell A, Sarma S.

BMJ Case Rep. 2019 Aug 10;12(8):e230389. doi: 10.1136/bcr-2019-230389.

Role of PGC-1α in Mitochondrial Quality Control in Neurodegenerative Diseases

Zhang Q, Lei YH, Zhou JP, Hou YY, Wan Z, Wang HL, Meng H.

Neurochem Res. 2019 Sep;44(9):2031-2043. doi: 10.1007/s11064-019-02858-6. Epub 2019 Aug 13.

Uncommon Movement Disorders in Chronic Hepatic Disease with Response to Rifaximin

Sousa AL, Salgado P, Alves JE, Silva S, Ferreira S, Magalhães M.

Tremor Other Hyperkinet Mov (N Y). 2019 Aug 2;9. doi: 10.7916/tohm.v0.649. eCollection 2019.

Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases

McAlary L, Plotkin SS, Cashman NR.

CNS Drugs. 2019 Sep;33(9):883-904. doi: 10.1007/s40263-019-00657-9.

Cytotoxicity models of Huntington's disease and relevance of hormetic mechanisms: A critical assessment of experimental approaches and strategies

Calabrese EJ, Bhatia TN, Calabrese V, Dhawan G, Giordano J, Hanekamp YN, Kapoor R, Kozumbo WJ, Leak RK.

Pharmacol Res. 2019 Dec;150:104371. doi: 10.1016/j.phrs.2019.104371. Epub 2019 Aug 12.

Neuroprotective Effects of Ginseng Phytochemicals: Recent Perspectives

Huang X, Li N, Pu Y, Zhang T, Wang B.

Molecules. 2019 Aug 14;24(16):2939. doi: 10.3390/molecules24162939.

Positron Emission Tomography in Pediatric Neurodegenerative Disorders

Chugani HT.

Pediatr Neurol. 2019 Nov;100:12-25. doi: 10.1016/j.pediatrneurol.2019.07.003. Epub 2019 Jul 17.

Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders

Yavarpour-Bali H, Ghasemi-Kasman M, Pirzadeh M.

Int J Nanomedicine. 2019 Jun 17;14:4449-4460. doi: 10.2147/IJN.S208332. eCollection 2019.

The pathobiology of perturbed mutant huntingtin protein-protein interactions in Huntington's disease

Wanker EE, Ast A, Schindler F, Trepte P, Schnoegl S.

J Neurochem. 2019 Nov;151(4):507-519. doi: 10.1111/jnc.14853. Epub 2019 Sep 15.

Speech in prodromal and symptomatic Huntington's disease as a model of measuring onset and progression in dominantly inherited neurodegenerative diseases

Chan JCS, Stout JC, Vogel AP.

Neurosci Biobehav Rev. 2019 Dec;107:450-460. doi: 10.1016/j.neubiorev.2019.08.009. Epub 2019 Aug 13.

Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease

Carlozzi NE, Goodnight S, Kratz AL, Stout JC, McCormack MK, Paulsen JS, Boileau NR, Cella D, Ready RE.

J Huntingtons Dis. 2019;8(4):467-482. doi: 10.3233/JHD-190364.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias